Stockreport

iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update

iBio, Inc.  (IBIO) 
NASDAQ:AMEX Investor Relations: ir.ibioinc.com
PDF Strengthened cash position and extended runway into the fourth quarter of fiscal year 2027 after closing underwritten public offering with up to potentially $100 million [Read more]